Basic Information
SETROF TABLET 50MG
TABLET, FILM COATED
Regulatory Information
SIN14221P
September 5, 2012
Prescription Only
Therapeutic
ORAL
August 10, 2023
June 3, 2025
XN06AB06
Company Information
Active Ingredients
Strength: 50mg
Detailed Information
Contraindications
**CONTRAINDICATIONS** - Contraindicated in patients with a known hypersensitivity to sertraline. - Concomitant use in patients taking monoamine oxidase inhibitors (MAOIs) is contraindicated. - Concomitant use in patients taking pimozide is contraindicated.
Indication Information
**INDICATIONS** Sertraline is indicated for the treatment of: 1. symptoms of depression, including depression accompanied by symptoms of anxiety, in patients with or without a history of mania. Following satisfactory response, continuation with sertraline therapy is effective in preventing relapse of the initial episode of depression or recurrence of further depressive episodes. 2. obsessive compulsive disorder (OCD). Following initial response, sertraline has been associated with sustained efficacy, safety and tolerability in up to 2 years of treatment of OCD. 3. panic disorder, with or without agoraphobia. 4. post-traumatic stress disorder (PTSD). 5. social phobia (social anxiety disorder). 6. premenstrual dysphoric disorder (PMDD).